IDH2 and cancer: More recently, succinate was found to be a prototypical ‘epigenetic hacker’[45], capable of inhibiting both DNA[46,47] and histone demethylases[48], leading to epigenetic changes that overlap with those observed in mutant IDH cancers[49].